Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
Publication
, Journal Article
Biggers, K; Scheinfeld, N
Published in: Curr Opin Investig Drugs
April 2008
Savient Pharmaceuticals Inc (formerly Bio-Technology General Corp), under license from Duke University, is developing pegloticase, PEG conjugates of uricase (urate oxidase), for the potential treatment of gout. The in-life portion of the phase III trials have been completed.
Duke Scholars
Published In
Curr Opin Investig Drugs
ISSN
1472-4472
Publication Date
April 2008
Volume
9
Issue
4
Start / End Page
422 / 429
Location
England
Related Subject Headings
- Urate Oxidase
- Treatment Outcome
- Structure-Activity Relationship
- Recombinant Proteins
- Polyethylene Glycols
- Pharmacology & Pharmacy
- Patents as Topic
- Molecular Structure
- Injections, Intravenous
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Biggers, K., & Scheinfeld, N. (2008). Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Curr Opin Investig Drugs, 9(4), 422–429.
Biggers, Kristen, and Noah Scheinfeld. “Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.” Curr Opin Investig Drugs 9, no. 4 (April 2008): 422–29.
Biggers K, Scheinfeld N. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Curr Opin Investig Drugs. 2008 Apr;9(4):422–9.
Biggers, Kristen, and Noah Scheinfeld. “Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.” Curr Opin Investig Drugs, vol. 9, no. 4, Apr. 2008, pp. 422–29.
Biggers K, Scheinfeld N. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Curr Opin Investig Drugs. 2008 Apr;9(4):422–429.
Published In
Curr Opin Investig Drugs
ISSN
1472-4472
Publication Date
April 2008
Volume
9
Issue
4
Start / End Page
422 / 429
Location
England
Related Subject Headings
- Urate Oxidase
- Treatment Outcome
- Structure-Activity Relationship
- Recombinant Proteins
- Polyethylene Glycols
- Pharmacology & Pharmacy
- Patents as Topic
- Molecular Structure
- Injections, Intravenous
- Humans